In conclusion, SIRT2 deficiency accelerates HFCS-induced NAFLD-NASH progression by inducing alteration of gut microbiota and changes of metabolites. The gene discussed is SIRT2; the disease is metabolic dysfunction-associated steatotic liver disease.